Antibodies
News
Wacker and XL-protein produce record yields of PASylated Fab antibody– 1-May-2013
Using Wacker E.coli-based ESETEC secretion technology
Boehringer Ingelheim signs manufacturing agreement with Apexigen– 6-Dec-2012
For process development and early stage clinical supply of monoclonal antibodies
Wacker broadens XL-protein collaboration– 31-Oct-2012
For the production of PASylated therapeutic proteins
Cobra Biologics and Algeta sign monoclonal antibody manufacturing agreement– 4-Sep-2012
Cobra to provide cell line development, cell banking, process development, scale-up, GMP production and stability studies
Genmab licenses HuMax-IL8 to Cormorant Pharmaceuticals– 30-May-2012
Human antibody will be evaluated for the treatment of selected cancers
GE Healthcare to acquire Xcellerex– 8-Mar-2012
Adds single-use manufacturing technology to portfolio
MorphoSys unveils new antibody technology– 6-Dec-2011
Ylanthia will show higher success rates and shorter timelines in antibody drug development
Piramal expands ADC manufacturing– 3-Nov-2011
Aims to be world number three CMO by 2016
New approach to curing viral infections– 17-Aug-2011
Developments at MIT’s Lincoln Laboratory could transform how viral infections are treated
GE Healthcare to acquire PAA Laboratories – 16-Aug-2011
Expands capabilities in biopharmaceutical manufacture
4-Antibody to collaborate with HGS– 16-Aug-2011
To discover and develop fully human therapeutic antibodies
Gilead to buy clinical biologics plant from Genentech– 10-Aug-2011
Will offer employment to 55 Genentech staff at plant in California